Lab Alumni

Postdoctoral Fellows

Carol Deminie, Ph.D.
Subject: Replication and assembly of chimeric retroviruses. 
Currently: Research Associate at Yale Cancer Research Center, New Haven, CT.

Paul Lewis, M.D.
8/91-8/93, Pediatric Infectious Disease Fellow
Subject: HIV infection of non-dividing cells. 
Currently: Associate Professor, Oregon Health Sciences University and Clackamas County Health Officer, Portland, OR.

Peter Gallombardo, Ph.D.
Subject: HIV-2 replication in non-dividing cells; deceased 8/95.

Wei-Chun Goh, M.D., Ph.D.
7/93-1/03 Infectious Disease Fellow
Subjects: Biochemical analysis of Vpr and genetic analysis of an exposed HIV seronegative cohort. 
Currently: Staff Physician, Internal Medicine/Infectious Diseases, Martinez, CA.

Steven Bartz, Ph.D.
Subject: Mechanisms of HIV-induced protection from apoptosis and induction of apoptosis. 
Currently: Vice President, Corporate Development, Seattle Genetics, Seattle WA

Marie Vodicka, Ph.D.
Subject: Intracellular trafficking of HIV. 
Currently: Senior Director Regulatory Affairs, Neogene Therapeutics, Inc,  San Francisco, CA

Rahm Gummuluru, Ph.D.
Subject: Mechanisms of HIV transmission between cells. 
Currently: Professor, Department of Microbiology, Boston University Medical School, Boston, MA.

Aleida Perez, Ph.D.
Subject: Role of HIV infection of non-dividing cells.
Currently: Staff Scientist, Office of Educational Programs, Brookhaven National Laboratory, Long Island, NY.

Timothy Dellit, M.D.
Infectious Disease Fellow; Subject: HIV population biology. 
Currently: Professor of Medicine, Associate Dean of Clinical Affairs, Associate Medical Director, Harborview Medical Center; University of Washington, Seattle, WA.

Sara L. Sawyer, Ph.D.
9/03-12/07, Joint mentorship with Harmit Malik.
Subject: Molecular evolution of host restriction factors.
Currently: Professor, BioFrontiers Institute, Department of MCDB, University of Colorado-Boulder, Boulder, CO.

Yegor Voronin, Ph.D. 
Subject: HIV Population Biology. 
Currently: Director, Academic Research Collaborations, Bristol Myers Squibb, Lawrence Township, NJ.

Masahiro Yamashita, Ph.D.
Subject: Role of Capsid in HIV infection of non-dividing cells. 
Currently: Principal Investigator, Columbia University Aaron Diamond AIDS Research Center, New York, NY

Lucie Etienne, Ph.D.
Subject: Adaptation of lentiviruses to hominoids. 
Currently: Assistant Professor (CR2, CNRS) at the International Center of Infectiology Research, CIRI, Lyon, France.

Oliver Fregoso, Ph.D.
Subject: Functions of Vpr. 
Currently: Assistant Professor, Microbiology, Immunology & Molecular Genetics, UCLA, Los Angeles, CA.

Jolien Vermeire, Ph.D.
Subject: Lentiviral restriction by interferon-stimulated genes. 
Currently: Senior Data Scientist, Biocartis, Saint-Gilles, Belgium.  

Ferdinand Roesch, Ph.D.
Subject: CRISPR screens for viral factors. 
Currently: Staff Scientist, INRE Val de Loire, Tours, France.

Nicholas Chesarino, Ph.D
Subject: Functional Evolution of Lentiviral Vif and APOBEC3 proteins
Currently: Lecturer, Department of Microbiology, College of Arts and Sciences, Ohio State University, Columbus, OH. 


Graduate Students

Vineet KewalRamani
6/90-6/96, Ph.D. in MCB and Microbiology Programs
Thesis title: Functional Analyses of Virion Associated Proteins Encoded by Immunosuppressive Retroviruses. 
Currently: Senior Investigator, Basic Research Laboratory, Head, Model Development Section, Center for Cancer Research, National Cancer Institute (NIH), Frederick, MD

Gina Stivahtis
8/94-8/99, Ph.D. in MCB program
Thesis Title: Evolution of Vpr function in Primate Lentiviruses. 
Currently: Attorney-at-Law

Robb Lowe
8/96-12/02, Ph.D. in MSTP program (joint with Ake Lernmark at Dept. of Medicine, UW)
Thesis Title: The role of AU repeats in the CTLA-4 gene in Type I Diabetes Susceptibility. 
Currently: Director, Juvenile Arthritis and Rheumatology Care and Research Center, Las Vegas, NV.

Nicolas Manel
8/00-8/01, D.E.A. before returning to graduate school with Marc Sitbon in Montpellier, France.
Project: Biochemical analysis of Vpr/Vpx. 
Currently: Team Leader, DR2 INSERM, Institut Curie, Paris, France.

Shari Kaiser
6/02-12/06, Ph.D. in MCB program
Thesis Title: Control of Retroviral Replication by Host Cell Factors. 
Currently: Director, Immuno-oncology and Cellular Therapy Translational Research at Bristol-Myers Squibb, Seattle, WA.

Molly OhAinle
8/03-12/07, Ph.D. in MCB program
Thesis Title: Adaptive Evolution and Loss of Function of a Primate Intrinsic Immunity Gene. 
Currently: Assistant Professor, Dept. of Molecular and Cell Biology (MCB), University of California-Berkeley

Tsai-Yu Lin
6/04-8/09, Ph.D. in Pathobiology program
Thesis Title: Functional Interaction of Primate Lentiviral Capsid with Host Factors. 
Currently: Assistant Professor of Clinical Medical and Molecular Genetics and Associate Director of Gene Therapy Testing Laboratory, Indiana University School of Medicine, Indianapolis, IN

Semih Tareen
6/05-5/10, Ph.D. in MCB program
Thesis Title: Molecular Consequences of Virus-Host Interactions as Inferred by the Function and Evolution of Host Antiviral Protein Trim5alpha. 
Currently: Executive Director, Sana Biotechnology, Seattle, WA.

Melody Li
6/07-6/11, Ph.D. in Microbiology
Thesis Title: Functional Consequences of Polymorphisms Found in a Human Antiviral Gene. 
Currently: Assistant Professor, Microbiology, Immunology & Molecular Genetics, UCLA, Los Angeles, CA.

Efrem Lim
6/08-2/12, Ph.D. in Microbiology
Thesis Title: fundmentals of the host-virus evolutionary arms race. 
Currently: Associate Professor, Biodesign Center for Fundamental and Applied Microbiomics Center for Viral Genomics, Arizona State University, Tempe, AZ.

Nisha Duggal
6/08-9/12, Ph.D. in MCB program
Thesis Title: The Ancient and Recurrent Evolution of Apobec3 Antiviral Activity in Primate. 
Currently: Associate Professor, Department of Biomedical Sciences & Pathology, Virginia Tech University, Blacksburg, VA.

Ray Malfavon-Borja
6/08-2/13, Joint Mentorship with Harmit Malik, Ph.D. in Genome Sciences program
Thesis Title: Learning from the past: Searching for novel TRIM, CypA, and TIMCyp antiviral factors in humans. 
Currently: TRIO McNair Project Coordinator, Undergraduate Studies, Cal State San Marcos, San Marcos, CA.

Alex Compton
6/09-12/12, Ph.D. in MCB program
Thesis Title: Virus-driven evolution of an antiviral gene in deep and shallow time. 
Currently: Investigator, HIV DRP Retroviral Replication Laboratory, NCI/CCR, Frederick, MA.

Patrick Mitchell
6/10-1/15, Joint Mentorship with Harmit Malik, Ph.D. in MCB program
Thesis Title: Evolution of antiviral breadth in Mx GTPases. 
Currently: Assistant Professor, Department of Microbiology, University of Washington

Cristina Wittkopp
6/13-6/16, Ph.D. in Microbiology
Thesis Title: The evolutionary history and activity of a gain-of-function polymorphism in a human antiviral gene. 
Currently: Sr. Patent Agent, 10x Genomics 

Erin Garcia
4/15-8/18, Ph.D. in MCB program
Thesis Title: Ancient loss of APOBEC3H activity in a clade of primates infected with SIV.
Currently: Staff Writer for ScienceNews

Rossana Colon-Thillet
6/15-3/19. Joint Mentorship with Harmit Malik. Ph.D. in MCB program
Thesis Title: Evolution-guided design of super restrictor antiviral proteins
Currently: Scientist, Sana Biotechnology

Mollie McDonnell
6/16-12/20, Ph.D. in MCB Program
Thesis Title: Super Restriction Factors against HIV-1 created from APOBEC3
Currently: Scientist, Umoja Biopharma, Seattle, WA

Emily Hsieh
9/18-2/23  Ph.D. in MCB Program
Thesis Title: Using a CRISPR-based screen to study individual and combination molecular mechanisms of HIV-1 latency
Currently:  Scientist, 2SeventyBio, Seattle WA

Vanessa Montoya
6/18-3/23  Ph.D. in MCB Program
Thesis Title: Genome scale identification of HIV dependency factors across multiple HIV-1 strains
Currently:  Scientist, Outpace Bio, Seattle WA